Brady W. Dougan, Director at Humacyte, Inc. (HUMA), bought 2,362 shares at $6.35 ($15K) on 2024-06-04, disclosed to the SEC on 2024-06-04.
Open-market purchase of $15k HUMA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |